NIAID Funding News, March 20, 2019

March 20, 2019 NIAID Funding News

Read this full issue online at http://www.niaid.nih.gov/grants-contracts/funding-news-notices

Feature Articles 

Follow Anti-Sexual Harassment Requirements

NIH leadership is determined to help address the problem of sexual harassment in NIH-funded research. Learn what to do if you're concerned about sexual harassment at your institution.

Opportunities and Resources

New FOA Supports Improved Cancer Immunotherapy Research

A new initiative supports research in the specific area of cancer immunotherapy associated with immune-related adverse events.

Propose Research on Radiation Countermeasures, AR Therapeutics, and AR Vaccine Candidates

Submit a contract proposal to carry out research in one of three areas: radiation countermeasures, therapeutics for antibiotic-resistant (AR) bacteria, and vaccine candidates for AR bacteria.

Apply To Develop Prevention Technologies Against Sexually Transmitted Infection and Pregnancy

NIAID seeks research into multipurpose prevention technologies that can simultaneously prevent HIV infection and pregnancy; sexually transmitted infections (STIs) and pregnancy; or multiple non-HIV STIs.

In The News

Keeping You Posted on Post-Submission Materials

Familiarize yourself with the updated policy on post-submission materials, including a change in page length for publication lists in training grant applications.

Respond to RFI on the NIH Hepatitis B Cure Strategic Plan by March 28

NIH seeks community input on a strategic plan to cure hepatitis B that aligns with NIH's ongoing efforts to intensify innovative hepatitis B research and the HHS-wide National Viral Hepatitis Action Plan.

NIAID Bumps Small Business Paylines Upward

We increased the payline for both Small Business Technology Transfer Phase I and II and Small Business Innovation Research Phase I and II applications to an overall impact score of 34.

Advice Corner

Write Your Application With Two Audiences in Mind

You need to write your application to perform two functions: first, to impress your assigned reviewers so they can act as advocates to the full study section; second, to explain your proposed research clearly and concisely to study section members who may not be experts in your field.

Reader Questions

• “Am I more likely to be funded if my budget request is frugal?”
• “Should I list postdoctoral researchers on my application’s Senior/Key Personnel Profile form?”

New Funding Opportunities

• RFA-AI-19-015, Atopic Dermatitis Research Network -Clinical Research Centers (U01, Clinical Trial Optional)
• RFA-AI-19-014, Atopic Dermatitis Research Network Leadership Center (UM1, Clinical Trial Required)
• RFA-AI-19-025, U.S.-South Africa Program for Collaborative Biomedical Research - Phase 2 (Infectious Diseases) (U01, Clinical Trial Optional)
• RFA-AI-19-024, U.S.-South Africa Program for Collaborative Biomedical Research - Phase 2 (Infectious Diseases) (R01, Clinical Trial Optional)
• RFA-AI-19-023, U.S.-South Africa Program for Collaborative Biomedical Research - Phase 2 (HIV/AIDS) (U01, Clinical Trial Optional)
• RFA-AI-19-022, U.S.-South Africa Program for Collaborative Biomedical Research - Phase 2 (HIV/AIDS) (R01, Clinical Trial Optional)

See other announcements at Opportunities & Announcements.

Send suggestions or comments to deaweb@niaid.nih.gov.